Yawen Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Newly Diagnosed

Multiple Myeloma

Top Venues

American journal of hematology

British journal of haematology

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jiadai Xu, Panpan Li, Yawen Wang, Jing Li, Bei Xu, Jiangyan Zhao, Chen Chen, Shiyang Gu, Chen Ding, Peng Liu
The role of proliferating stem-like plasma cells in relapsed or refractory multiple myeloma: Insights from single-cell RNA sequencing and proteomic analysis. British journal of haematology (2024)
Yawen Wang, Jiadai Xu, Bei Xu, Panpan Li, Yang Yang, Wenjing Wang, Tianhong Xu, Aziguli Maihemaiti, Tianwei Lan, Pu Wang, Liang Ren, Chi Zhou, Xianmuseye Aihemaiti, Peng Liu
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse. Cancer (2023)
Yawen Wang, Jiadai Xu, Bei Xu, Panpan Li, Yang Yang, Wenjing Wang, Tianhong Xu, Aziguli Maihemaiti, Tianwei Lan, Pu Wang, Liang Ren, Chi Zhou, Xianmuseye Aihemaiti, Peng Liu
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse. Cancer 129 (7) (2023)
Yawen Wang, Jiadai Xu, Bei Xu, Panpan Li, Yang Yang, Wenjing Wang, Tianhong Xu, Aziguli Maihemaiti, Tianwei Lan, Pu Wang, Liang Ren, Chi Zhou, Xianmuseye Aihemaiti, Peng Liu
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse. Cancer 129 (7) (2023)
Yawen Wang, Jiadai Xu, Bei Xu, Panpan Li, Yang Yang, Wenjing Wang, Tianhong Xu, Aziguli Maihemaiti, Tianwei Lan, Pu Wang, Liang Ren, Chi Zhou, Xianmuseye Aihemaiti, Peng Liu
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse. Cancer 129 (7) (2023)
Yawen Wang, Hongwei Xue, Wei Song, Shuxin Xiao, Fanjing Jing, Tieying Dong, Lili Wang
Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China. Hematological oncology 40 (4) (2022)
Yawen Wang, Mingzhi Zhang, Wei Song, Qing-Qing Cai, Liling Zhang, Xiuhua Sun, Liqun Zou, Huilai Zhang, Lili Wang, Hongwei Xue
Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial. American journal of hematology 97 (5) (2022)